December 2020

The following is the latest COVID-19 information from the federal governments as of 2:45 p.m. on Friday, December 4. Centers for Medicare & Medicaid Services CMS has updated its FAQs on Medicare fee-for-service billing with 14 new questions that address administration and billing for monoclonal antibody therapy.  The new questions can be found on pages 33-34, p. 34, pp. 120-121, p. 121, pp. 121-124, pp. 124-125, p. 125 (four questions), p. 126, pp. 126-127, p. 127, and pp. 127-128. CMS covers much the same ground in an updated version of its document “Medicare Monoclonal Antibody COVID-19 Infusion Program Instruction.” CMS [...]

The following is the latest COVID-19 information from the federal government as of 2:45 p.m. on Wednesday, December 2. Centers for Medicare & Medicaid Services CMS has announced the introduction of two new Medicare condition codes that will take effect for claims received on or after February 1, 2021:  one to enable providers to report when a service is provided as part of Expanded Access approval and another to enable providers to report when the service is provided as part of an Emergency Use Authorization.  Find an article about the new codes here in MLN Matters, CMS’s online publication. CMS [...]